Adam Broder

Adam Broder designs and executes multistakeholder advocacy campaigns to help companies manage and mitigate political, reputational and regulatory risks. Adam advises clients across industries on how to communicate effectively during moments of change and crisis, including government investigations, high-stakes litigation, executive transitions, regulatory scrutiny and business transformation.

As part of FTI Consulting Strategic Communications’ Healthcare & Life Sciences team, Adam counsels global healthcare companies in the health insurance, provider and pharmaceutical sectors on communications, advocacy, stakeholder engagement, scenario planning and other business strategies, as they relate to regulatory approval, payer-provider rate negotiations, drug pricing, M&A and global political risks.

In addition, Adam advises companies facing political, regulatory, reputational and operational scrutiny in the automotive, airline, semiconductor and financial services industries, particularly companies with matters before the U.S. Department of Justice (“DOJ”), U.S. Securities and Exchange Commission (“SEC”), Federal Trade Commission (“FTC”) and National Highway Traffic Safety Administration (“NHTSA”), among other federal regulatory agencies.

Prior to FTI Consulting, Adam was a Senior Campaign Strategist for the Democratic Party and served as Research Director and Strategic Communications Adviser at the Democratic Congressional Campaign Committee (“DCCC”), where he developed strategies to drive local and national press engagement for campaigns in nearly every state.

Adam also provided counsel to members of Congress and their campaigns on reputation defense strategies against political attacks, voter and media engagement, crisis communications and effective earned and paid media plans.